PRESS DIGEST- New York Times business news - November 25

Reuters11-25
PRESS DIGEST- New York Times business news - November 25

Nov 25 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.

- Danish company Novo Nordisk NOVOb.CO announced on Monday that two large studies failed to find any effect of the drug semaglutide on cognition and functioning in people with mild cognitive impairment, an early stage of Alzheimer's or with dementia.

- The U.S. Consumer Financial Protection Bureau said it would now require its financial examiners to recite a humility pledge to companies before beginning a review.

- U.S. President Donald Trump said he had accepted an invitation from his Chinese counterpart Xi Jinping to visit Beijing in April. That occurred while the two leaders discussed several major issues between their nations, including Taiwan, the war in Ukraine and Chinese purchases of American soybeans.

(Compiled by Bengaluru newsroom)

((globalnewsmonitoring@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment